Urbanization and policy support to promote development of pharmaceutical industry two favorable factors. The steady progress of urbanization will be the pharmaceutical market expansion and rapid growth of the industry a powerful driving force. The introduction of new medical reform plan, will greatly enhance the health insurance coverage to a wider range of people to enjoy affordable health services, medicines and medical equipment to stimulate the growth of consumption. Support policies and a large number of inputs, the pharmaceutical industry will bring new development opportunities
In the context of such an era, SF Medical Co., Ltd. will assume more pharmaceutical manufacturers and hospitals, pharmacies and other end markets as a bridge between, and to participate in this competition is so fierce in the market place. SF Medical Ltd was founded in 1995, is a company with 15 years of state-owned joint venture, engaged in drug sales agency management, and ability to provide logistics and distribution companies. Is the earliest country has GSP certification and ISO9001 quality system certification of pharmaceutical enterprises, mainly engaged in proprietary Chinese medicines, chemical medicine preparation, chemical medicine, antibiotics, biochemical drugs, biological products, the second psychotropic drugs (agents), protein assimilation preparations and peptide hormones as well as medical devices.
This paper describes the development of domestic and foreign pharmaceutical commercial enterprises current situation and development trends, as well as the SF Medical Ltd, a leading pharmaceutical business of domestic enterprises to develop the healthy development of marketing strategies, in order to help more SF Medical Co., Ltd. better adapt to a changing pharmaceutical industry environment.
Keywords: SF company, medicine, marketing strategy